期刊文献+

胸部CT检查对乳腺癌临床早期诊断的价值分析 被引量:3

The value of chest CT scan for early diagnosis of breast cancer
下载PDF
导出
摘要 目的:探讨胸部CT检查对乳腺癌临床早期诊断的临床价值。方法:收治乳腺癌患者60例,所有患者均经针吸细胞学检查或手术病理证实。所有患者均采用双层螺旋CT检查,分析检查结果。结果:早期乳腺癌的CT影像学特征,本组60例早期乳腺癌病理类型:小管癌3例,小叶癌3例,单纯癌4例,导管内癌13例,浸润性导管癌37例。早期乳腺癌的主要影像学征象:肿块有毛刺影,长短不一,偶见伪足,形肿块状不规则,质地不均匀且有明显钙化,见局部皮肤增厚,钙化灶呈泥沙样、针尖样或条索样,若侵犯胸壁可见肿块周围腺体密度增高、腋下淋巴结肿大、乳腺后脂肪间隙完全消失。结论:胸部CT检查具有灵敏度高、检查无痛苦,是诊断早期乳腺癌的重要手段之一。 Objective:To explore the value of chest CT scan for early diagnosis of breast cancer.Methods:60 patients with breast cancer were selected.All patients were diagnosed by needle aspiration cytology or surgical pathology.All patients were given double helical CT examination,and we analyzed the results of the examination.Results:CT imaging features of early breast cancer:early breast cancer pathological type of 60 cases in this group:3 cases of tubular carcinoma,3 cases of small tumor,4 cases of simple carcinoma,13 cases of catheter carcinoma,37 cases of invasive ductal carcinoma.Imaging appearances of early breast cancer:the mass had burr shadow,the length was different,pseudopod were rare,occasionally pseudopodia and swollen lump shape were irregular,the texture was not uniform and it had calcification.The local skin was thickened,and the calcification was the sediment sample,the needle tip sample or the cord like.If the tumor invaded the chest wall,the density of the gland around the tumor increased,the axillary lymph nodes were enlarged,and the fat clearance after the mammary gland was disappeared completely.Conclusion:Chest CT examination had high sensitivity and there was no pain.It was one of the important methods for diagnosis of early breast cancer.
作者 马荣国
出处 《中国社区医师》 2015年第28期110-110,112,共2页 Chinese Community Doctors
关键词 胸部CT检查 早期乳腺癌 诊断价值 Chest CT examination Early breast cancer Diagnostic value
  • 相关文献

参考文献3

  • 1N. Harbeck,M. Schmitt,C. Meisner,C. Friedel,M. Untch,M. Schmidt,C.G.J. Sweep,B.W. Lisboa,M.P. Lux,T. Beck,S. Hasmüller,M. Kiechle,F. J?nicke,C. Thomssen.Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients[J]. European Journal of Cancer . 2013 (8)
  • 2Barry PA,Schiavon G,Mac Neill FA.Letter to the editor on’’Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer:results from the Neo ALTTO phaseⅢtrial’’. Annals of Oncology . 2014
  • 3von Minckwitz G,Rezai M,Fasching PA,et al.Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40-Gepar Quattro). Annals of Oncology . 2014

同被引文献14

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部